Zyversa Therapeutics Inc (ZVSA)

Jun 16, 2025

Critical Analysis: ZyVersa Therapeutics (NASDAQ:ZVSA) vs. Schrödinger (NASDAQ:SDGR) - Defense World

Jun 16, 2025

Jun 14, 2025

ZyVersa Therapeutics (NASDAQ:ZVSA) Upgraded at Wall Street Zen - Defense World

Jun 14, 2025

Jun 12, 2025

ZyVersa Therapeutics Stockholders Approve Key Proposals - TipRanks

Jun 12, 2025

Jun 11, 2025

Reviewing Belite Bio (NASDAQ:BLTE) & ZyVersa Therapeutics (NASDAQ:ZVSA) - Defense World

Jun 11, 2025

Jun 06, 2025

At $0.65 Price, ZyVersa Therapeutics Inc (ZVSA) Is Sitting And Waiting - Stocksregister

Jun 06, 2025

Jun 05, 2025

ZyVersa Therapeutics Reports Q1 2025 Financial Results - TipRanks

Jun 05, 2025

May 31, 2025

ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) Sees Large Drop in Short Interest - Defense World

May 31, 2025

May 20, 2025

ZVSA: ZyVersa Therapeutics' IC 100 Shows Promise in PD Treatment - GuruFocus

May 20, 2025

May 20, 2025

ZyVersa’s IC 100 shows promise in Parkinson’s treatment By Investing.com - Investing.com India

May 20, 2025

May 20, 2025

ZyVersa Therapeutics highlights publication of data on IC 100 - TipRanks

May 20, 2025

May 20, 2025

ZyVersa’s IC 100 shows promise in Parkinson’s treatment - Investing.com Australia

May 20, 2025

May 20, 2025

ZyVersa Therapeutics Highlights Published Study Reinforcing - GlobeNewswire

May 20, 2025

May 20, 2025

Breakthrough Study Reveals Key to Fighting Parkinson's: ZyVersa's Novel Drug Shows Promise in $13B Market - Stock Titan

May 20, 2025

May 12, 2025

ZyVersa Therapeutics, Inc. Provides Pipeline and Financial Update: Advances in Clinical Trials for VAR 200 and IC 100 - Nasdaq

May 12, 2025

May 12, 2025

ZyVersa Therapeutics Reports First Quarter 2025 Financial Results and Highlights Pipeline Progress - GlobeNewswire

May 12, 2025

May 09, 2025

Retail Traders Flock To ZyVersa As IC 100 Obesity Plan Looks To Fill GLP-1 Gaps - MSN

May 09, 2025

May 08, 2025

Retail Traders Flock To ZyVersa As IC 100 Obesity Plan Looks To Fill GLP-1 Gaps By Stocktwits - Investing.com India

May 08, 2025

May 07, 2025

ZyVersa Unveils Groundbreaking Potential of Inflammasome - GlobeNewswire

May 07, 2025

May 07, 2025

ZyVersa Therapeutics announces developments on inflammasome inhibitors - TipRanks

May 07, 2025

May 07, 2025

ZyVersa progresses with obesity inflammation treatment - Investing.com Australia

May 07, 2025

May 07, 2025

ZyVersa Unveils Potential Of Inflammasome Inhibitors In Combination With GLP-1 Agonists To Address Needs Of People Living With Obesity - marketscreener.com

May 07, 2025

May 07, 2025

ZyVersa Unveils Groundbreaking Potential of Inflammasome Inhibitors in Combination with GLP-1 Agonists to Address Unmet Medical Needs of People Living with Obesity; Provides R&D Update - Stock Titan

May 07, 2025

Apr 30, 2025

ZyVersa Therapeutics Inc [ZVSA] is -36.75% lower this YTD. Is it still time to buy? - dbtnews.com

Apr 30, 2025

Apr 29, 2025

ZyVersa Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - investchronicle.com

Apr 29, 2025

Apr 29, 2025

How does ZVSA’s price to cash per share ratio compare in the market? - uspostnews.com

Apr 29, 2025

Apr 29, 2025

Study finds inflammation-targeting drug has Parkinson’s potential - Longevity.Technology

Apr 29, 2025

Apr 29, 2025

ZVSA: ZyVersa Therapeutics Unveils Promising Data on Parkinson's - GuruFocus

Apr 29, 2025

Apr 29, 2025

Zyversa Therapeutics Announces Published Data Showing Inflammasome Asc Inhibitor IC 100 Decreases Microglial Inflammasome Activation - marketscreener.com

Apr 29, 2025

Apr 29, 2025

ZVSA: ZyVersa Therapeutics Unveils Promising Data on Parkinson's Treatment | ZVSA Stock News - GuruFocus

Apr 29, 2025

Apr 29, 2025

ZyVersa Therapeutics Announces Promising Data for Inflammasome ASC Inhibitor IC 100 in Parkinson's Disease Research - Nasdaq

Apr 29, 2025

Apr 29, 2025

ZyVersa Therapeutics Announces Published Data Showing - GlobeNewswire

Apr 29, 2025

Apr 29, 2025

Game-Changing Parkinson's Treatment: Nature Study Reveals Drug's Dual-Action Against Disease Progression - Stock Titan

Apr 29, 2025

Apr 24, 2025

ZyVersa progresses with novel inflammation treatment By Investing.com - Investing.com South Africa

Apr 24, 2025

Apr 24, 2025

ZyVersa progresses with novel inflammation treatment - Investing.com

Apr 24, 2025

Apr 24, 2025

ZyVersa Therapeutics CEO Issues Shareholder Letter - GlobeNewswire

Apr 24, 2025

Apr 24, 2025

ZyVersa's IC 100 Drug Targets $186B Market, Sets 2025 Clinical Timeline | ZVSA Stock News - Stock Titan

Apr 24, 2025

Apr 22, 2025

ZyVersa Therapeutics files to sell 4.21M shares of common stock by selling shareholders - MSN

Apr 22, 2025

Apr 10, 2025

Why ZyVersa Therapeutics, Inc. (ZVSA) Went Down On Thursday? - Yahoo Finance

Apr 10, 2025

Apr 10, 2025

10 Stocks Fall Behind Amid Market Optimism - Insider Monkey

Apr 10, 2025

Apr 09, 2025

ZyVersa CEO outlines progress in kidney disease drug development - Investing.com

Apr 09, 2025

Apr 09, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Apr 09, 2025

Apr 08, 2025

ZyVersa Therapeutics Reports 2024 Financial Results and Progress - TipRanks

Apr 08, 2025

Apr 08, 2025

ZyVersa CEO outlines progress in kidney disease drug development By Investing.com - Investing.com South Africa

Apr 08, 2025

Apr 08, 2025

ZyVersa Therapeutics (ZVSA) Highlights Potential of IC 100 for O - GuruFocus

Apr 08, 2025

Apr 08, 2025

ZyVersa Therapeutics (ZVSA) Reports 2024 Financial Results and P - GuruFocus

Apr 08, 2025

Apr 08, 2025

ZyVersa Therapeutics (ZVSA) Secures $2 Million Through Securitie - GuruFocus

Apr 08, 2025

Apr 08, 2025

ZyVersa CEO issues shareholder letter on PARASOL recommendations - TipRanks

Apr 08, 2025

Apr 08, 2025

ZyVersa Therapeutics CEO Issues Shareholder Letter on PARASOL Recommendations Expected to Reduce Drug Development Barrier for Rare Kidney Disease, Focal Segmental Glomerulosclerosis (FSGS) - GlobeNewswire

Apr 08, 2025

Apr 07, 2025

ZyVersa Therapeutics appoints new accounting firm - Investing.com

Apr 07, 2025

Apr 07, 2025

ZyVersa Therapeutics appoints new accounting firm By Investing.com - Investing.com India

Apr 07, 2025